[ascct] Fwd: Register for our Human Tissue for Safety Assessment workshop

  • From: Kristie Sullivan <KSullivan@xxxxxxxx>
  • To: "ascct@xxxxxxxxxxxxx" <ascct@xxxxxxxxxxxxx>
  • Date: Tue, 3 Jun 2014 12:55:28 -0400

This may be of interest to some.

Begin forwarded message:

From: NC3Rs News <News@xxxxxxxxxxxx<mailto:News@xxxxxxxxxxxx>>
Subject: Register for our Human Tissue for Safety Assessment workshop
Date: June 3, 2014 at 3:00:54 AM PDT
To: NC3Rs News <News@xxxxxxxxxxxx<mailto:News@xxxxxxxxxxxx>>



The NC3Rs and Medicines and Healthcare Products Regulatory Agency (MHRA) are 
working together to host a workshop aimed at addressing the barriers for uptake 
of human tissue approaches for safety assessment of new drugs.

The intended audience is key influencers from industry, contract research 
organisations, regulatory bodies, researchers developing human tissue models 
applicable in this area, and companies providing human tissue services to the 
research community.

Attendance at the meeting is free, but registration is essential. The closing 
date for registrations is 1 July 2014.

Key objectives:

 *   Share experiences and best practice in the use of human tissue for safety 
assessment, focussing particularly on safety pharmacology.
 *   Identify and address the barriers to uptake of human tissue-based 
 *   Work as a community in developing a strategy for overcoming some of the 
barriers to wider uptake of human tissue-based approaches to benefit safety 
assessment and the 3Rs.
 *   Provide a forum for linking safety scientists with experts in the 
development and application of human tissue models to translate these 
approaches in to safety assessment.

Active participation in the workshop is essential. Participants are encouraged 
to submit posters relating to human tissue-based approaches to safety 
assessment and the 3Rs. The deadline for submitting poster abstracts is 10 June 

For further information, please contact 


To ensure our emails are delivered to your inbox and not your junk folder,
please add the email address news@xxxxxxxxxxxx<mailto:news@xxxxxxxxxxxx> to 
your address book or 'safe' list.

This communication is confidential and may contain privileged information 
intended solely for the named recipient(s) only. It may not be used or 
disclosed except for the purpose for which it has been sent. If you are not the 
intended recipient, you must not copy, distribute, take any action or reliance 
on it. If you have received this communication in error, do not open any 
attachments but please notify NC3Rs by e-mailing 
enquiries@xxxxxxxxxxxx<mailto:enquiries@xxxxxxxxxxxx> quoting the sender 
details, and then delete this message along with any attached files. E-mail 
messages are not secure and attachments could contain software viruses which 
may damage your computer system. Whilst every reasonable precaution has been 
taken to minimise this risk, We cannot accept any liability for any damage 
sustained as a result of these factors. You are advised to carry out your own 
virus checks before opening any attachments. Unless expressly stated, opinions 
in this message are those of the e-mail author and not of the NC3Rs.

JPEG image

JPEG image

JPEG image

JPEG image

Other related posts:

  • » [ascct] Fwd: Register for our Human Tissue for Safety Assessment workshop - Kristie Sullivan